l(2)k10317k10317/l(2)k10317[+] is a suppressor of visible phenotype of DysRNAi.NH2.UAS, Scer\GAL4Act.PU
l(2)k10317k10317/l(2)k10317[+] is a suppressor of visible phenotype of DysRNAi.C.UAS, Scer\GAL4Tub.PU
l(2)k10317k10317/l(2)k10317[+] is a suppressor of posterior crossvein phenotype of DysRNAi.NH2.UAS, Scer\GAL4Act.PU
l(2)k10317k10317/l(2)k10317[+] is a suppressor of posterior crossvein phenotype of DysRNAi.C.UAS, Scer\GAL4Tub.PU
DysRNAi.NH2.UAS, l(2)k10317k10317/l(2)k10317[+] has wing vein | ectopic phenotype
DysRNAi.C.UAS, l(2)k10317k10317/l(2)k10317[+] has wing vein | ectopic phenotype
One copy of l(2)k10317k10317 strongly suppresses the detached posterior crossvein phenotype seen when DysdsRNA.NH2.Scer\UAS is expressed under the control of Scer\GAL4Act.PU but produces extra wing vein material.
One copy of l(2)k10317k10317 moderately suppresses the detached posterior crossvein phenotype seen when DysdsRNA.C.Scer\UAS is expressed under the control of Scer\GAL4tub.PU but produces extra wing vein material.
I. Kiss.
Deficiency complementation analysis is consistent with the lethality of the line being associated with the insertion. The insertion maps within the MESK2 transcription unit. However, since the insertion lies within a gene-rich region, the lethality can not yet be conclusively mapped to a single gene from these results. Thus l(2)k10317k10317 (representing the lethality of the chromosome) has been kept as a separate allele in FlyBase for now.
Complements: Fkbp1300734. Complements: MESK201467. Complements: Egfr05351. Complements: MESK208882. Complements: Sdc10608.